This session will provide attendees with practical information on how to individualize drug therapies for patients living with chronic kidney disease. The landscape of diagnosis and management of CKD is continually evolving, with evidence-based recommendations changing dramatically in the past few years. This session will provide an overview of these crucial and timely updates with an opportunity for attendees to apply the evidence to simulated patient cases while focusing on overcoming therapeutic inertia and advocating for equitable care.

This activity is approved for Board Certified Ambulatory Care Pharmacist (BCACP) and Board Certified Geriatric Pharmacist (BCGP) recertification credit.

The BCACP/BCGP Clinical Sessions are part of the professional development program for the recertification of board-certified ambulatory care pharmacists and board-certified geriatric care pharmacists by the Board of Pharmacy Specialties and jointly provided by ACCP and the American Society of Health-System Pharmacists (ASHP). In order to earn the BCACP or BCGP recertification credit, participants must attend the session, claim the continuing pharmacy education credit, and pass the associated posttest. Access to the BCACP/BCGP Clinical Sessions posttests will be available on February 7, 2024, at www.accp.com/myaccount to anyone who has purchased access to the BCACP or BCGP posttests. For participants who have not purchased access to the posttest, access can be purchased until 5:30 p.m. on Tuesday, November 14, at the ACCP Registration Desk. The deadline to submit posttests for these sessions will be December 17, 2024.

Faculty

Speaker: Lalita Prasad-Reddy, Pharm.D., MS, FCCP, BCACP, BCPS, CDE Title: BCACP/BCGP Clinical Session — Filtering Out the Old, and Reabsorbing the New: Updates in the Management of Chronic Kidney Disease Institution: City/State: Chicago, IL   View Biography